Immune mediated disorders in women with a fragile X expansion and FXTAS

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajmg.a.36748PMID 25399540PMCID PMC4275322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

  2013cited by this paper
• Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome.

  2013cited by this paper
• Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging

  2013cited by this paper
• FXTAS: New Insights and the Need for Revised Diagnostic Criteria (S20.006)

  2013cited by this paper
• Fragile X‐associated tremor/ataxia syndrome (FXTAS) in grey zone carriers

  2013cited by this paper
• FXTAS

  2012cited by this paper
• Unique immunologic patterns in fibromyalgia

  2012cited by this paper
• Immune‐mediated disorders among women carriers of fragile X premutation alleles

  2012influential reference
• Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice

  2011cited by this paper
• Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.

  2011cited by this paper
• A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome.

  2011cited by this paper
• Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome.

  2011cited by this paper
• Fibromyalgia in fragile X mental retardation 1 gene premutation carriers.

  2011cited by this paper
• Fibromyalgia: from pathophysiology to therapy

  2011cited by this paper
• Alternative splicing in multiple sclerosis and other autoimmune diseases

  2010cited by this paper
• Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.

  2010cited by this paper
• Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients

  2010cited by this paper
• Co‐occurring diagnoses among FMR1 premutation allele carriers

  2010cited by this paper
• Advances in understanding the molecular basis of FXTAS.

  2010cited by this paper
• MicroRNA in the immune system, microRNA as an immune system

  2009cited by this paper
• A review of fragile X premutation disorders: expanding the psychiatric perspective.

  2009cited by this paper
• Mood and anxiety disorders in females with the FMR1 premutation

  2009cited by this paper
• Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome

  2009cited by this paper
• Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers

  2009cited by this paper
• FMR1 CGG repeat length predicts motor dysfunction in premutation carriers

  2008cited by this paper
• Heat shock protein derivatives for delivery of antigens to antigen presenting cells.

  2008cited by this paper
• Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

  2008cited by this paper
• Expanded clinical phenotype of women with the FMR1 premutation

  2008influential reference
• A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

  2008cited by this paper
• Dementia in fragile X‐associated tremor/ataxia syndrome (FXTAS): Comparison with Alzheimer's disease

  2008cited by this paper
• Advances in microRNAs: implications for immunity and inflammatory diseases

  2008cited by this paper
• Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome.

  2008cited by this paper
• Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS)

  2007influential reference
• Elevated FMR1 mRNA in premutation carriers is due to increased transcription.

  2007cited by this paper
• Amygdala dysfunction in men with the fragile X premutation.

  2007cited by this paper
• Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.

  2007cited by this paper
• Neuropathic features in fragile X premutation carriers

  2007influential reference
• Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).

  2006influential reference
• Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: A clinical–pathological study

  2006cited by this paper
• Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation

  2006cited by this paper
• Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia.

  2006cited by this paper
• [Fragile X-associated tremor/ataxia syndrome].

  2005cited by this paper
• Association of FMR1 repeat size with ovarian dysfunction.

  2005cited by this paper
• Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation

  2005cited by this paper
• Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson’s disease

  2004cited by this paper
• Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

  2003influential reference
• Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.

  2002cited by this paper
• Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

  2002cited by this paper
• Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

  2000cited by this paper
• Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.

  1997cited by this paper
• Heat shock proteins in multiple sclerosis and other autoimmune diseases.

  1993cited by this paper
• RESEARCH ARTICLE Open Access Systematic review with meta-analysis: cytokines

  year unknowncited by this paper

• SPTAN1—Results of a Caregiver Survey

  2025cites this paper
• C G composition in transposon-derived genes is increased in FXD with perturbed immune system

  2024cites this paper
• Characterization of Fragile X Mental Retardation Protein expression in human nociceptors and their axonal projections to the spinal dorsal horn

  2023cites this paper
• Glial dysregulation in the human brain in fragile X-associated tremor/ataxia syndrome

  2023cites this paper
• Developments, trends, and publication opportunities in sports medicine: Bibliometric analysis

  2022cites this paper
• Spectrum of Syndromal Disorders Associated with Expansion of CGG Repeats of the FMR1 Gene Promoter: Pathogenetic Mechanisms and Clinical Manifestations

  2022cites this paper
• Tophaceous gout of the nose in a male FMR1 premutation carrier

  2022cites this paper
• Beyond Moco Biosynthesis―Moonlighting Roles of MoaE and MOCS2

  2022cites this paper
• Prevalence of Fragile X-Associated Tremor/Ataxia Syndrome in Patients with Cerebellar Ataxia in Japan

  2021cites this paper
• Stress and genetics influence hair cortisol in FMR1 premutation carrier mothers of children with fragile X syndrome.

  2021cites this paper
• Women with Fragile X–associated Tremor/Ataxia Syndrome

  2020cites this paper
• Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction

  2020cites this paper
• The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders

  2020cites this paper
• The quest towards understanding the molecular pathogenesis of triplet repeat disorders: Huntingtons Disease and Fragile X-Associated Tremor and Ataxia Syndrome

  2020cites this paper
• General Anesthetic Use in Fragile X Spectrum Disorders

  2019cites this paper
• Changes in Neuroimmune and Neuronal Death Markers after Adolescent Alcohol Exposure in Rats are Reversed by Donepezil

  2019cites this paper
• [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

  2019cites this paper
• Fragile X-Associated Neuropsychiatric Disorders (FXAND)

  2018cites this paper
• Health problems in females carriers of premutation in the FMR1 gene.

  2017cites this paper
• Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases

  2017cites this paper
• Aging in Fragile X Premutation Carriers

  2016cites this paper
• Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management

  2016cites this paper
• Premutation-Associated Disorders in Childhood and Adulthood

  2016cites this paper
• Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series

  2016cites this paper
• A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population

  2015cites this paper
• Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis

  2015cites this paper